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Abstract
Background/Aims—Efforts to improve individual and population health increasingly rely on
large scale collections of human biological specimens and associated data. Such collections or
“biobanks” are hailed as valuable resources for facilitating translational biomedical research.
However, biobanks also raise important ethical considerations, such as whether, how and why
biobanks might engage with those who contributed specimens. This paper examines perceptions
and practices of community engagement (CE) among individuals who operate six diverse
biobanks in the U.S.
Methods—Twenty-four people from a diverse group of six biobanks were interviewed in-person
or via telephone from March-July, 2011. Interview transcripts were coded and analyzed for
common themes.
Results—Emergent themes include how biobank personnel understand “community” and
community engagement as it pertains to biobank operations; information regarding the diversity of
practices of CE; and the reasons why biobanks conduct CE.
Conclusion—Despite recommendations from federal agencies to conduct CE, the interpretation
of CE varies widely among biobank employees, ultimately affecting how CE is practiced and what
goals are achieved.
I Introduction
The Centers for Disease Control and Prevention (CDC) has emphasized the importance of
community engagement (CE) in improving the public’s health, and the quality and
applicability of population research in general [1]. Over time, federal agencies such as the
National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality
(AHRQ) have joined the CDC in emphasizing the benefits of CE, to “…build trust, enlist
new resources and allies, create better communication and improve health outcomes [1].” At
the same time, efforts to improve individual and population health increasingly rely on large
scale collections of human biological specimens and associated data. Such collections or
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“biobanks” comprise an emerging industry with a valuable resource for facilitating effective
translational biomedical research. What is not clear, however, is whether biobanks respond
to calls for community engagement, and how and why they might engage in CE with those
who contributed specimens and data as well as communities at large.
Biobanks are remarkably heterogeneous organizations [2] which vary in size, mission,
acquisition of specimens, and population of contributors; they may be independent,
commercial organizations, or embedded within academic institutions, hospitals, government
programs, disease advocacy organizations, and more. Such differences are likely to have
implications for how a biobank may approach the desirability, design, and implementation
of their community engagement efforts. Additionally, although the CDC, NIH, AHRQ, and
others emphasize the importance of CE, no organization offers a set of guidelines for
individuals or organizations endeavoring to conduct CE. Given this, we aimed to examine,
using qualitative methods, the perceptions and practices of community engagement by a
diverse group of biobanks.
Origins of Community Engagement
Although its origins date back to the 1940s in the work of educator and philosopher Paolo
Freire, CE was not readily adopted in U.S. health research until recent decades when it was
first used to address population-level racialized and gendered health disparities[1,3,4]. It was
heralded as an important approach to health problems that included the attitudes and beliefs
of traditionally under- or mis-represented subpopulations in the design and implementation
of public health interventions. Community input was perceived as a way to avoid “scientific
racism”--or the use of scientific study to justify superiority of one “race” over another--when
attempting to study minority groups [5], while improving the success of public health
interventions in health outcomes including heart disease, high blood pressure and preterm
delivery, among others [1,5,6]. While CE was defined and operationalized differently in
these studies, its perceived success meant that CE became an expected part of much public
health intervention research.
The world of acronyms that emerged to identify models of CE reflects its definitional
ambiguity. These frameworks include the best known version, CBPR (community-based
participatory research) [7-9] as well as empowerment evaluation; participatory or
community action research; participatory rapid appraisal [10]; CPPR (community-partnered
participatory research) [11], CEnR (community-engaged research) [12]; and the framework
favored by clinical researchers, PCI (patient-centered initiatives) [13]. These “rhetorical
cousins” [12] appear to fall under the larger umbrella of CE, and it is often difficult to
understand their differences. Thus, in both literature and in practice, many of these
approaches appear to stand in for one another [1,14].
In 1997, the CDC, along with the Agency for Toxic Substances and Disease Registry,
published an initial handbook, “Principles of Community Engagement.” With growing
recognition by the clinical and translational sciences community that CE is an essential
component of successful translation of medicine “from bench to bedside to community,” the
Clinical and Translational Science Award (CTSA) call for proposals in 2006 included a
strong infrastructural component for CE. In 2011, the CTSA Consortium’s Key Function
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Community Engagement Committee updated the 1997 handbook entitled “Principles of
Community Engagement [1].” This most recent version notes that CE in health research is
“the process of working collaboratively with groups of people who are affiliated by
geographic proximity, special interests, or similar situations with respect to issues affecting
their well-being” and “…is increasingly recognized as a vital component of efforts to
expand access to quality care, prevent disease, and achieve health equity for all Americans”
(p.xv) [1]. Active participation in CE, as described in the Principles of Community
Engagement, refers to researcher and participant operating as “partners” in research design,
execution, analysis and dissemination of results. Its desired goals are to create and maintain
long-term partnerships between researchers and the communities they serve in order to
improve health equity and overall health and quality of life for all [1,6,7,15]. This definition
of the overall goals of CE in translational research is echoed by Ross and colleagues, who
also write that growing interest in CE is evidence of an “…emergent moral sensitivity of the
research community to the value of engaging with the communities in which they seek to do
research” (p.3) [16]. Overwhelmingly, public health practitioners and bioethicists perceive
CE as a benefit for those engaging in research as well as the communities they serve
[7,14,15,17]. Despite the growing recognition of CE as a vital paradigm in health research,
according to some authors, its practices remain underdeveloped [18,19], and as the CDC
notes, “…the processes, costs and benefits of community engagement are still a relatively
new field of study”(p.8) [1].
The practice and implementation of community or public engagement activities in response
to ethical, legal and social concerns regarding genetic information and research has received
attention from authors examining large-scale prospective genetic studies, particularly the
establishment and operation of national or other large genetic databases [20-24]. Some have
delved more in-depth into the meanings of “participation” in an effort to better understand
how community members act as participants in research studies and thus illuminate the
kinds of engagement that are possible [23]. Tutton and colleagues examine participation in
the context of citizenship and national genetic databases, hinting at a partnership model of
engagement whereby “people can participate in genetic databases not only as the sources of
blood samples and data but also as potential co-decision makers” (p.177)[23]. Likewise,
researchers engaged in large-scale genetic studies have explored the kinds of input and
character of community-researcher interactions that long-term prospective studies may
require [20-22] . While recognizing the value of ongoing communication with communities
they also note the complexity of such work, including increased cost, difficulties in practical
implementation of activities, understanding its clear purpose and a meaningful evaluation of
such activities over time [22].
In the context of biobanking, Lemke and colleagues explain the benefits of CE in terms of
ethical behavior for research generally: “Demonstrating respect for persons who volunteer to
participate in research is an ethical good in itself. Moreover, by taking the initiative to
engage their respective communities, researchers lay the groundwork to foster mutual
understanding and trust, encourage public interest and participation in research, and
potentially enhance the impact of their studies” (p.51) [19]. They describe CE as “an
important step in ensuring that biobank research is carried out in an ethical, locally
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appropriate manner, including a spectrum of community involvement used to inform,
consult, involve, collaborate with or empower communities” [19]. Others have noted that
purposes of CE include establishing trust in a biobank [25], guarding against a loss of trust
in science [26] or to enhance the professionalization of biobanks [24].
As part of a large population-based biobank, McCarty and colleagues [20,27] draw a stark
contrast between their work involving ongoing, bi-directional flow of dialogue and ideas
with community members and one-way engagement efforts aimed at informing a public and
eliciting information from them [28]. In their examination of human tissue banking in B.C.,
Canada, O’Doherty and Hawkins [26]specifically addresses the lack of information
regarding the translation of such dialogue into policy.
Lemke and colleagues [19] call attention to the need for more literature on approaches to CE
specifically tailored to biobanks and their participants. Our study of six U.S. biobanks
addresses this gap in the literature, using qualitative interviews to explore how biobanking
personnel understand community and community engagement, and how those
understandings translate into practice. We argue that despite recommendations from federal
agencies to conduct community engagement, its meaning is widely interpreted among
biobank employees, thus affecting how its goals are perceived and ultimately how it is
practiced.
II Materials and Methods
A. Study Background
The larger study from which these interviews are taken is a mixed-methods project including
case studies of six biobanks, with data drawn from qualitative interviews and document
analysis, and an online national survey of 456 biobanks in the U.S. [2,29]. We designed the
case studies of biobanks to be an exploratory study that would ultimately inform the design
of our national survey. The six cases were chosen based on their sample procurement
methods: de novo—human biological samples newly obtained from participants for future
research; re-purposed—human biological samples obtained from leftover specimens
collected for clinical or public health purposes; and networked—human biological samples
obtained through channels of networked banks. Ultimately, we discovered that sample
procurement method was not an analytically valuable way to examine our data, so we do not
highlight it in our results below. We have named the six biobanks: community, national,
hospital, state, advocacy and disease-focused. A description of these six biobanks can be
found in Table 1.
B. Interviews and Analysis
Biobank personnel who fit one of several pre-determined roles were interviewed for this
study. Although these roles were loosely defined and often challenged in the study
recruitment process, they were useful starting points for selecting respondents. The roles
include: Principal Investigator; Study Coordinator; Information Technician; Institutional
Review Board member; and Public Relations officer. Our qualitative research team of four
social scientists collaboratively developed interview questions over the course of three
Haldeman et al. Page 4






















months and presented each version of the interview guide to the larger multidisciplinary
biobank study group for feedback. Interview topics included the history and mission of the
biobank, its structure, policies and practices regarding certain ethical, legal, and social issues
(ELSI) of biobanking such as ownership of the specimens and informed consent procedures,
and the biobank’s relationships with the researchers who use the specimens (see Table 2 for
representative questions from each topic). Importantly for this analysis, we also asked many
questions about the biobank’s relationships with the community of potential and actual
specimen contributors (referred to below as participants [23]) Some questions were asked to
all interviewees, others were developed specifically for each biobank personnel role. All
interviewees were recruited to participate in the interview as representatives of their
particular biobank, and the vast majority of questions did not solicit individuals’ opinions;
however, some interviewees offered their personal opinions about different topics at
different points throughout the interview.
From March through July, 2011, we conducted semi-structured interviews with a total of 24
biobank personnel, either in-person or by telephone. Interviews averaged about 60 minutes.
We present here responses to interview questions regarding biobank interactions with
specimen contributors, probing for specific efforts that were considered part of community
engagement.
All interviews were digitally recorded and transcribed verbatim. We used qualitative
analysis software NVivo 9.0™ to collect and analyze interview data. Using discussions with
the larger research group, close readings of interviews, and conversations among our team,
we developed a codebook with specific attention to sample procurement methods,
organizational features, key ELSI and other themes of interest that emerged from the full set
of interviews. All coding was carried out by four individuals on the qualitative team. Coding
validity was ensured by multiple coders analyzing a sample of interviews followed by
discussion until consensus around coding and strategies was reached. Changes to the
codebook were made collaboratively by all members of the qualitative research team.
We analyzed the interviews through close readings of full transcripts and generating reports
[using NVivo 9.0™] from specific codes that reflected themes of interest (e.g., community;
community engagement; trust). Summaries of codes of interest and overall written
summaries of findings for each biobank were provided to the larger research group.
Members of the qualitative team then met several times for discussion of patterns and
findings from each case and from the six biobanks as a whole. Results below are presented
for biobanks identified by pseudonyms that provide general information about the bank’s
organizational form (Table 1).
III Results
Three themes emerged from our interviews with biobank personnel who fit one of the
above-mentioned roles. Themes included: how respondents understood community and CE;
how people who work for biobanks practice CE; and why biobanks conduct CE.
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A. How biobanks understand community and community engagement
Our interviews revealed that definitions of community and CE varied across the biobanks
and even across respondents within the same biobank. First, we’ll discuss understandings of
community. Community was seen both as monolithic and as comprised of different
components. Some respondents indicated a broader sense of community as a large
population from which to collect samples while others viewed community as a specific
subset of larger populations, such as a hospital-based or disease-focused community. Still
others considered research and scientific communities in their explanations. One respondent
explained that a community consists of individuals and groups: “Well, I think there’s
different levels. You know certainly the… individuals who are in it – they make up a
community, but then there’s also the…more formal groups that might exist within a
community.” Another respondent referred to the community in more monolithic terms: “…
the project leader established a community advisory board which is another advisory board
soliciting input from community leaders who aren’t necessarily within the health care or
research field, but also nonetheless they’re leaders in the community and sort of have their
finger on the pulse of the community at large.”
Another interviewee from a community biobank also referred to community in terms of
group and individual characteristics. She explained CE as a two-way form of
communication with multiple types of potential participants, stressing its reciprocal nature.
I interpret it literally. I mean that we are not thinking of them as a research
population. That we are engaging them. It’s participatory. They get an opportunity
to have a voice in how the research is done, what research is done. They are – the
communication is two way. We’re not taking things from them, data and samples,
and leaving them on their own. We are continually re-engaging them and
identifying their needs and trying to meet them. We think of the community as all
sorts of sub-communities. I mean a population is a population. It’s also churches,
networks, schools, families, employers. And so there – we engage them. It’s about
– it’s about bidirectional communication I think. Hearing them.
In addition to understanding community in a variety of ways, respondents’ views of CE
varied. For some biobanking personnel, CE was used as an educational tool, a guideline for
communication with participants, and a way to stay informed about the needs, concerns and
opinions of potential participants.
A respondent from a hospital biobank remarked that CE was intentionally built into the
structure of the biobank, with the creation of specific plans, boards and oversight by
bioethics experts. Interestingly, his overall understanding of the goal of CE is about
changing or monitoring the attitudes of the local patient community about the biobank rather
than engaging individuals as participants.
We have a very large community engagement element. And so it includes a
specific community engagement plan that is monitored by the bioethics committee,
has the formally constituted community advisory board that meets on a regular
basis at least three times a year. It has a continuing review about whether the
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changing expectations for genetic research in the community are changing the…
community view of [us].
In this way, CE involves a one-way process of monitoring the community to ensure that
their (currently positive) view of the biobank is not changing. Another view situated CE
similarly, with information about the biobank flowing into its targeted community as a
means of educating the people being recruited into the biobank. A respondent from a state
biobank described it as a process aimed at research consent:
…we’ve done some presentations to groups like that…certainly our initial big push
has been more educating about the consent process that was being implemented
and trying to get to prospective parents because at this point it’s the most relevant
for them to be informed so they can make their decision.
Another interviewee viewed CE “in other studies” as a way to ask community members to
help recruit new participants, but in her national biobank, CE was used as a tool for both
recruitment and education:
…we don’t do community engagement where we actually go to community groups
and tell them you know “Hey. Help us recruit here.” Or “Help us you know
advertise the study to your community.” And things like that like you would for
community engagement in other studies, but we do go out into communities. …we
go to community groups for recruitment. We go to churches…. we’ve gone to
street fairs and things like that. So we actually do go out into the community to
recruit, and at the same time we hope that we’re sort of educating them a little bit
about these types of studies, biobanks and genetic studies and things like that.
With no clear definition of community, as “levels, ”sub-communities,“ and
interstitial ”leaders“ abound, it is not surprising that respondents have different ideas of what
constitutes community engagement. Most, however, seemed to believe it involved an
element of education, especially as it relates to recruitment and enrollment of potential
participants.
B. How biobanks conduct CE
Beyond understanding the meanings of CE for these biobank personnel, our aim was to
understand the processes that comprised CE efforts. Our findings reveal multiple ways of
conducting CE which, like conceptions of CE discussed in the previous section, involve both
uni-directional and bi-directional activities aimed to educate potential participants about the
purpose and activities of the biobank.
One interviewee from a state biobank described CE in terms of community forums the
biobank orchestrated for the public, noting the forums failed as isolated (”standalone”)
events because of lack of attendance:
We did actually try holding a couple just community information forums, but they
were not successful as a standalone kind of thing. …we tried to hold one [in town]
where we just invited anybody who wanted to learn about it to come, and I think
we had some of our health department staff show up. … We had two other people.
We had a member of our (community advisory board) who wanted to just come
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and see what we were doing, and then the other person …was a parent, but he was
mainly there because he was also a researcher, and he wanted to find out how to
use the samples in his research…
This respondent perceived that this lack of participation reflected disinterest in the
information, rather than as potentially linked to inadequate advertising or to lack of support
for the biobank itself.
Finally, other respondents insisted they did not conduct CE formally, but spoke of it as an
informal process. A representative from a state biobank suggested that CE involves
delivering information to potential participants, but considers anyone he may connect with
as a potential recipient of his personal engagement efforts:
I consider it community engagement no matter who I’m speaking to… I’ve been to
conferences…and I’ve spoken to groups of researchers. I went to Best Buy to make
a purchase and filled out the tax exempt form, and out of curiosity the woman
behind the counter said “Huh. What is the State Biobank?” And I explained it to
her. I consider that to be community engagement.
As noted by respondents above, some biobanks have established community advisory
boards (CABs) as part of CE. When asked about the challenges and successes of the state
biobank, a representative spoke about their CAB:
We now have the citizens’ advisory group and with that well in place we were able
to move forward with confidence that the citizens know or are well represented in
making decisions about the [biobank]. So it was a challenge in that there was quite
a bit of time involved and getting people up to speed, and forming the citizens’
advisory board – that was the challenge. The success is that it’s working, is that we
truly have citizen involvement. This isn’t in name only. It isn’t a token position. …
This is real. These folks actually have a say in what goes on, and that’s been our
biggest success.
This interviewee’s confidence in the success afforded by a “real” citizen advisory group
seems linked to the notion advanced by some proponents of CE that forming a CAB is an
ethical activity because it means community members are “well represented” in decision
making. In fact, another representative from the state biobank noted that the way they
engage ethics is through their CAB: “… we have the community advisory board that can
keep us on the straight and narrow with ethical issues.”
When asked about issues that biobankers felt were important to convey to potential
participants, a representative of a community biobank referenced consent and the forms of
CE aimed at information sharing and education:
I mean it’s not just reading one consent form. We send newsletters. We have
events. We do science fairs. We do lots and lots of community sort of education
sessions in churches and schools and all over the place.
Although this person appeared interested in engagement efforts, she saw them as
opportunities for one-way communication--from the biobank to potential participants in
order to educate and inform.
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A respondent from a state biobank talked about CE in terms of understanding public
perceptions of the biobank via a direct gauge of its “temperature.” He indicated that such
engagement was designed to address public perceptions regarding the ethics of using stored
specimens:
…the ethical issue was why don’t we go take the temperature of some of the rest of
the public to find out how they feel about it. So with very, very limited resources…
we started going hither and yon and talking to folks in focus group kinds of settings
to find out what people thought about it, and in the main the results…showed that
the vast majority of people that we talked to were in fact thinking that this (using
stored samples for research) was a good idea and not objectionable.
Interestingly, public responses that affirmed the use of stored specimens resulted in this
respondent feeling as though the public supported the state biobank, which may or may not
have been a correct assumption.
A respondent from a national biobank indicated that energy spent in attending a variety of
community events was instrumental in increasing enrollment:
We went forward and just started going into the community, and we ended up
going to things like the Dixie Gun and Knife Show, and the Septic Tank
Association had a conference, and we went to that, and home and garden shows,
just anything like that, and it was astounding how well we did with things like that.
I’m just trying to think of some of the men’s groups. We attended some of the
African American male fraternity conferences and did great….I think as a whole
we’re higher than what we would have been had we stayed continually with the
patient enrollment in the clinics.
A biannual newsletter was another CE platform for this biobank, as the interviewee
explained:
…we just recently started doing a newsletter that’s going out, and that’s going out
every six months… That needed to happen from the beginning because…
seventeen thousand people I’ve come in contact with, and I run into some people
who know us. They’ll see… the booth, and they’ll be like “Hey. So you know are
you…guys publishing any results? Are you doing anything?”
In this excerpt, the respondent highlights the newsletter as a way to give back to participants
and also indicates, via the feedback he has received, that contributors hold the biobank to
some level of accountability. He also appears to recognize the one-way nature of a
newsletter, wishing for more interactive communication with participants. However, another
employee of the same biobank noted that when personal contact is achieved in order to
annually update contact information there may be unanticipated and undesirable outcomes
for the biobank:
When we get into the phone call re-contacting, we have a spike in withdrawals
because people are contacted directly, and it’s easier for folks to say “I’m not
interested anymore.”
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CE thus becomes a double-edged sword whereby efforts at forming relationships with
participants, although they may be valued, may become avenues for people to re-evaluate
their participation in the study.
For the biobanks in our study, CE involves many different kinds of activities, some more
interactive than others. Some biobanks have CABs whose purposes are to provide specific
input to guide various stages of the biobanking enterprise. Some banks send newsletters to
participants or publish their research findings in local papers. More active forms of
engagement involve setting up focus groups, or talking with people at various community
venues including fairs, churches and schools. These more active undertakings are usually
intended to identify what might motivate participation or encourage people to enroll.
Continued engagement after enrollment may remind them that contributors are expecting
results and productivity, or may inadvertently “backfire” when communication provides an
easy mechanism for withdrawal. However, as we explore in the next section, many of our
respondents discussed how processes of CE may create public support and trust in
biobanking efforts.
C. Why biobanks conduct CE
Some of our interviewees perceived a close relationship with participants through CE and
valued their relationships in interesting ways. One representative from a hospital biobank
felt that procedures of engaging participants should include expressions of gratitude and
promotion of a sense of sharing between researcher and participant:
I think the messages that we need to communicate to them are that this is an
important foundation for research and that we appreciate their willingness to let us
do this and that we need to share with them the kinds of things that we’re
learning….
A state biobank employee values what she perceives as “public support” in order to ensure
biobank sustainability:
I think that the primary risk is not continuing to have public support. I mean you
need public support in order for this to be sustainable to be successful. So I think
while you’re doing all these other things, coordinating the research, better
preserving the specimens, garnering that interest in their use, you have to put as
much emphasis and precedent on engaging and educating the community about
what you’re doing and making sure you’re still continuing down a path that the
public finds acceptable because things shift and change with time.
Reconnecting with participants and receiving their feedback permits biobankers to
understand how attitudes and beliefs about the bank change over time, ultimately enabling it
to remain viable and, in this respondent’s eyes, successful.
An employee of an advocacy biobank provided a relational understanding of CE that may be
unique to advocacy contexts:
Some of them [other advocacy organizations] don’t really even have the
connections with their community. So I know they’re not going to be successful.
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People donate to these because they have the relationship with the advocacy group.
For the same reason people will participate in their physician’s clinical trial. It’s all
relationship based.
She feels that CE ought to be about establishing relationships with your participants and that
these relationships are necessary to succeed as a biobank.
For a representative from a community biobank, one of the greatest risks the biobank faces
is losing or not gaining the trust of the local community. Her words indicate the amount of
emotional energy spent on understanding local perceptions of genomic research and their
biobank specifically:
I feel like the stakes are high. And so it’s almost like the bar is higher because we
had to go a long way to gain people’s trust and to set the foundation. And so I
worry that we don’t have much room for human error because I feel like potentially
the backlash could be great. … I am very serious in communicating to the staff
“Folks, we need to do this right. We absolutely need to do it right.” … We’ve
worked really hard to get into this community, and this is their first experience with
research.
Another employee from the same community biobank described its potential participants as
a “research naïve community” and explained CE efforts to establish trust through the work
of two advisory boards:
This is a research naïve community. … Really this community has no idea what
research means. They don’t even know what the word research means. So it’s all
about educating them about research in general, and then with that said what is a
biobank? I mean that concept is sometimes hard to grasp…. it’s very nebulous. You
know we’re going to take your blood and some information from you, and we don’t
know what we’re going to do with it. And so educating them on what that is, what
it means, why we need blood samples, what are we going to do with the blood
samples. …so it’s educating, and it’s establishing trust. …we have a health care
advisory board and a community advisory board. So they are kind of our liaisons to
the community and our advocates in the community.
Thus the goal of establishing trust was seen as part of improving recruitment. Similarly, a
respondent from a national biobank reports feeling a particular emotional closeness with
some long term participants--people she recruited and whose samples and re-contact she
handled:
…all the follow-up that we’ve had from people like in re-contacting all the people,
all the notes and things like that that we’d get back from people it seems like it’s
been very, very positive. I actually got a long note about a week ago from this
woman… telling me about her husband or somebody who had just died of a certain
disease and saying how she’s really grateful for studies out there. You know it had
– the note was awful. I’ll start crying if I think about it.
As indicated in the responses above, CE takes many forms with widely differing
interpretations of value and meanings, applications in the biobanking research context, goals
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and measures to reach them. While CE may be a way for biobankers to show appreciation to
participants, they also seem to fear what might happen to the biobank if they fail to conduct
CE. Fears included potential for difficulty in recruiting participants and whether or not the
bank would secure funding and thus increase chances for sustainability. Thus, they may
view CE as a way to improve their research or to show appreciation to participants, yet their
motivations may also come from fears of catastrophe--including closure of the biobank--
should they fail to engender the community’s trust and support.
IV. Discussion
A great deal of attention has been paid to the idea of community engagement in a wide
variety of fields, including biobanking [1,4,7,13-15,19,30-32]. Particularly in response to
concerns about the inadequacy of informed consent for biobanking, a number of authors
have argued that CE should be included as one component of a new and robust governance
approach [33]. Community engagement, in itself, is often seen as leading to better, more
appropriate and effective research [1]--the most positive rendition of the model aspires to
create an egalitarian researcher-participant relationship, a partnership [1,7]. Despite these
reported benefits of CE, no individual or organization has endeavored to provide guidance to
biobanks as to what CE encompasses and how to achieve it. As the literature suggests and
our research demonstrates, the ambiguity of the term has contributed to uncertainty as to
what CE means, how it is performed and what it aims to achieve. Our findings reveal that
this ambiguity leads to confusion about what it encompasses and whether it is successful in
its efforts to partner with communities with the end result of enhancing the quality of
biobanking research.
Defining communities is a problematic process that has yet to be fully understood in the
literature or in practice [12,19,34,35]. Following Weijer [36], Gbadegesin and Wendler [37]
suggest that groups of people identified as communities have particular attributes when
specifically participating in health research: “…common culture, political authority, shared
resources, and self-identification as a community.” However, at least in the context of
biobanking, our data demonstrate that meanings of community are far more complex. For
biobankers, well-defined, circumscribed participant groups may or may not exist prior to
banking efforts. If biobanks are established to contribute to research on a specific
community, the target of CE is pre-defined. In other circumstances, potential biobank
participants may share very few attributes. Associations with one another may be as loose as
attending the same hospital one time or living in the same broad geographical area. This
variation contributes to both the conceptual and practical confusions that confront
biobankers as they attempt to engage “their communities.”
Results of interviews from our biobank case studies also reveal different methods of
engagement. These methods can vary both in depth and in duration. They may range from a
single newsletter to a process of re-contact, or the development of a CAB. Among
respondents in our study, the imperative to engage communities often translates into ideas
about “educating the community” in the hopes of, at best, enrolling participants, or at least,
convincing community members of the value of the biobank so as not to oppose its
practices. This motivation to sustain the biobank is understandable, but its link to “education
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focused” CE is problematic. Education becomes a delivery of information, making
reciprocity (and the ability to derive information that informs the policies and practices of
the bank) hard to discern.
Multiple views of both community and engagement are problematic for biobanks that are
supposed to do community engagement in order to be more ethical in their practices and
relationships. However CE is interpreted, it can hold such sway that researchers interpret it
as sufficient for the ethical conduct of research. In some cases, it seems to appear as a proxy
for ethical practice itself, with its emphasis on respect for the voices and participation of
participants. As Lemke and colleagues note, “(F)rom an ethical standpoint, community
engagement offers an opportunity to show respect for the individuals and communities
involved in research and it may also be instrumental in preventing barriers to future
research” (p.51) [19] . Outward measures of this respect vary greatly, however, and can
reflect motivations compatible or incompatible with views of respect.
CABs are one approach used by researchers, including biobanks, to demonstrate respect
(practice CE) [19,25,31]. However, a biobank’s conceptualization of their participant
“community” may limit how well the participants who sit on the CAB represent the
communities from which donors are recruited. When bank participants are drawn from very
large and diverse populations within a hospital system or geographic area, it may be
exceedingly difficult to adequately represent the various religious, cultural, and ethnic
groups that make up the communities from which donors are recruited. Even in cases where
a community may be more defined and the members of a CAB are chosen carefully to be
representative, it should not be assumed that this type of committee can account for the
voices of all community members [38].
In a field as heterogeneous as biobanking, it is unlikely that specific engagement efforts will
work equally well across all banks. As Newman notes, these efforts--both in conception and
practice--deserve further attention:
Engaging vulnerable community stakeholders in medical research is less of a
controlled and predictable science than we might wish. Nevertheless, it seems
curious that we invest millions of dollars in product development, clinical training,
design and building of facilities, etc., but often leave vital processes of community
engagement largely to trial and error. [32]
It seems as though CE is in danger of becoming a useless buzzword; the term is ambiguous
and almost completely devoid of empirical evidence as to what works, in what contexts, and
importantly, to what effects. Moreover, there are no agreed-upon ways to evaluate CE. Some
biobankers may view their efforts as successful if they increase enrollment in the biobank.
Others may feel that as long as their community of potential participants is not actively
objecting to the biobank’s activities, their CE efforts have succeeded. And yet, one of the
purported benefits of conducting CE is increasing public trust in biobanking. With so many
different notions of CE, and no agreed-upon way to measure and evaluate efforts, public
trust seems likely to erode over time.
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We acknowledge that this study has limitations in both the sample of respondents and
potential for individual bias. Our sample size is small, the types of biobanks were
heterogeneous, and within our sample, we interviewed people occupying different roles
within each biobank. Thus, it may not be surprising that respondents’ views of community
and perceptions and practices of community engagement varied. Though we believe
examining community engagement among a larger sample of biobankers is important,
results from our recent survey of biobankers also reveal tremendous heterogeneity among
biobanks’ organizational characteristics and practices (Henderson et al. 2013).However, we
believe that our respondents’ varied responses to these issues also reflect the current state of
the field of community engagement; that is, there is little guidance for biobanks on how to
engage communities that is responsive to the heterogeneity of biobanks, and virtually no
discussion of how to define or measure successful community engagement efforts.
In order to address individual bias, as we have noted in our methods, our team of qualitative
researchers met regularly upon completion of interviews to discuss responses and emergent
themes. Discussion among researchers took place until consensus around patterns and
themes of respondents was reached. In order to address interviewer bias, we selected short
segments of a cross-section of interviews for all team members to analyze for codebook
development and overall analysis.
VI. Conclusion
Although there have been recent efforts to more clearly define practical steps for CE in
clinical research, its meanings, practice and measures of success remain under-examined in
biobanking [15,25]. In this study, biobank personnel reported that their bank conducted CE
in order to build trust and relationships with specimen contributors; give back to those who
participated; enhance recruitment; and for what they described as ethical reasons.
Community engagement efforts aimed at establishing trust were seen as part of improving
recruitment to the biobanks we studied. According to our interviews, CE was primarily used
to educate the community of potential participants and also to establish trust so that
participants join or to enhance the chances of bank sustainability. Ultimately, more research
is necessary to further explore and clarify the unique meanings of community within
different biobanking contexts, as well as varying biobank methods of community
engagement and its benefits to the participants and the research enterprise. A better
understanding of the various ways in which biobanks engage communities, and how those
efforts impact those communities over time may help those who wish to create new banks to
consider their own relationships with potential participants and thus understand more fully
what it means to be ethical.
Acknowledgments
We wish to thank the people who generously gave of their time and expertise to participate in these interviews. We
also thank Robert Mitchell and Bryan Weiner for their assistance with the case studies. Funding for this project was
provided through the following grants: 1R01HG005227-01A1 (Henderson, G., PI, “From Specimen to Biobank:
Using An Organizational Perspective To Study ELSI Issues”) from the NHGRI, and 5UL1RR025747-04S1, a
supplement to U54RR024382-01A1 (Runge, M., PI, “Enhancing Biobank Capacities Across CTSAs”). Support was
Haldeman et al. Page 14






















also provided by the UNC Center for Genomics and Society, P50 HG004488 from the NHGRI. The content of this
article does not necessarily reflect the views or policies of the funding agencies.
REFERENCES
1. McCloskey DJ, McDonald MA, Cook J, Heurtin-Roberts S, Updegrove S, Sampson D, et al.
PRINCIPLES OF COMMUNITY ENGAGEMENT. 2011
2. Henderson GE, Cadigan RJ, Edwards TP, Al. E. Characterizing biobank organizations in the U.S.:
results from a national survey. Genome medicine. 2013
3. Cornwall A, Jewkes R. WHAT IS PARTICIPATORY RESEARCH ? Soc Science and Medicine.
1995; 41:1667–1676.
4. Shalowitz MU, Isacco A, Barquin N, Clark-Kauffman E, Delger P, Nelson D, et al. Community-
based participatory research: a review of the literature with strategies for community engagement.
Journal of developmental and behavioral pediatrics : JDBP. Aug.2009 30:350–61. [PubMed:
19672162]
5. Rowley, D.; Tosteson, H., editors. Racial differences in preterm delivery: developing a new research
paradigm. Oxford University Press; New York: 1993.
6. Israel, B a; Schulz, a J.; Parker, E a; Becker, a B. Review of community-based research: assessing
partnership approaches to improve public health. Annual review of public health. Jan.1998 19:173–
202.
7. Minkler, M.; Wallerstein, N. The growing support for CBPR [Internet]. In: Minkler, M.;
Wallerstein, N., editors. Community-based participatory research for health: from process to




8. Wallerstein N, Duran B. Community-based participatory research contributions to intervention
research: the intersection of science and practice to improve health equity. American journal of
public health. Apr 1; 2010 100(Suppl):S40–6. [PubMed: 20147663]
9. Horowitz CR, Robinson M, Seifer S. Community-based participatory research from the margin to
the mainstream: are researchers prepared? Circulation. May 19.2009 119:2633–42. [PubMed:
19451365]
10. Ahmed SM, Palermo A-GS. Community engagement in research: frameworks for education and
peer review. American journal of public health. Aug.2010 100:1380–7. [PubMed: 20558798]
11. Chung B, Jones L, Jones A, Corbett CE, Booker T, Wells KB, et al. Using community arts events
to enhance collective efficacy and community engagement to address depression in an African
American community. American journal of public health. Feb.2009 99:237–44. [PubMed:
19059844]
12. Juengst, ET. Community Engagement in Genetic Research: The “Slow Code” of Research Ethics?
[Internet]. In: Knoppers, BM., editor. Populations and Genetics: legal and Socio-Ethical
Perspectives. Martinus Nijhoff Publishers; Leiden: 2003. p. 181-198.
13. Anderson N, Bragg C, Hartzler A, Edwards K. Participant-Centric Initiatives: Tools to Facilitate
Engagement In Research. Applied & Translational Genomics. Oct.2012 DOI:10.1016/j.atg.
2012.07.001.
14. Ahmed, Sayed M.; Palermo, Ann-Gel S. Community Engagement in Research: Frameworks for
Education and Peer Review [Internet]. American Journal of Public Health. 2010; 100:1380–1387.
[cited 2012 Sep 18]; Available from: http://ajph.aphapublications.org.libproxy.lib.unc.edu/doi/pdf/
10.2105/AJPH.2009.178137. [PubMed: 20558798]
15. Isler MR, Corbie-Smith G. Practical Steps to Community Engaged Research: From Inputs to
Outcomes. The Journal of law, medicine & ethics : a journal of the American Society of Law,
Medicine & Ethics. Dec.2012 40:904–914.
16. Ross LF, Loup A, Nelson RM, Botkin JR, Kost R. Human Subjects Protections in Community-
Engaged Research: A Research Ethics Framework. Journal of Empirical Research on Human
Research Ethics. 2010; 5:5–17. [PubMed: 20235860]
Haldeman et al. Page 15






















17. Beskow LM, Dean E. Informed consent for biorepositories: assessing prospective participants’
understanding and opinions. Cancer epidemiology, biomarkers & prevention : a publication of the
American Association for Cancer Research, cosponsored by the American Society of Preventive
Oncology. Jun 1.2008 17:1440–51.
18. Tindana PO, Rozmovits L, Boulanger RF, Bandewar SVS, Aborigo R a, Hodgson AVO, et al.
Aligning community engagement with traditional authority structures in global health research: a
case study from northern Ghana. American journal of public health. Oct.2011 101:1857–67.
[PubMed: 21852635]
19. Lemke AMYA, Wu JT, Waudby C, Pulley J, Carol P, Trinidad SB. Community engagement in
biobanking : Experiences from the eMERGE Network. 2010; 6:50–67.
20. Clayton EW, Smith M, Fullerton SM, Burke W, McCarty C a, Koenig B a, et al. Confronting real
time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE)
Consortium. Genetics in medicine : official journal of the American College of Medical Genetics.
Oct.2010 12:616–20. [PubMed: 20733502]
21. Godard B, Marshall J, Laberge C. Community engagement in genetic research: results of the first
public consultation for the Quebec CARTaGENE project. Community genetics. Jan.2007 10:147–
58. [PubMed: 17575459]
22. Avard D, Knoppers BM. Genomic medicine: considerations for health professionals and the
public. Genome medicine. Jan.2009 1:25. [PubMed: 19341496]
23. Tutton R. Constructing Participation in Genetic Databases: Citizenship, Governance, and
Ambivalence. Science, Technology & Human Values. Mar 1.2007 32:172–195.
24. Hewitt RE. Biobanking: the foundation of personalized medicine. Current opinion in oncology.
Jan.2011 23:112–9. [PubMed: 21076300]
25. McCarty, C a; Garber, A.; Reeser, JC.; Fost, NC. Study newsletters, community and ethics
advisory boards, and focus group discussions provide ongoing feedback for a large biobank.
American journal of medical genetics Part A. Apr.2011 155A:737–41. [PubMed: 21572889]
26. O’Doherty KC, Hawkins A. Structuring public engagement for effective input in policy
development on human tissue biobanking. Public health genomics. Jan.2010 13:197–206.
[PubMed: 20395688]
27. McCarty, C a; Chapman-Stone, D.; Derfus, T.; Giampietro, PF.; Fost, N. Community consultation
and communication for a population-based DNA biobank: the Marshfield clinic personalized
medicine research project. American journal of medical genetics Part A. Dec 1.2008 146A:3026–
33. [PubMed: 19006210]
28. Ormond KE, Cirino AL, Helenowski IB, Chisholm RL, Wolf WA. Assessing the understanding of
biobank participants. American journal of medical genetics Part A. Feb.2009 149A:188–98.
[PubMed: 19161150]
29. Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE. Neglected ethical
issues in biobank management: Results from a U.S. Study. Life Sciences, Society and Policy. Mar.
2013 9:1.
30. Lemke, a a; Wolf, W a; Hebert-Beirne, J.; Smith, ME. Public and biobank participant attitudes
toward genetic research participation and data sharing. Public health genomics. Jan.2010 13:368–
77. [PubMed: 20805700]
31. Dickert N, Sugarman J. Ethical goals of community consultation in research. American journal of
public health. Jul.2005 95:1123–7. [PubMed: 15983268]
32. Newman PA. Towards a science of community engagement [Internet]. The Lancet. 2006:302. cited
2012 Sep 17.
33. O’Doherty KC, Burgess MM, Edwards K, Gallagher RP, Hawkins AK, Kaye J, et al. From consent
to institutions: designing adaptive governance for genomic biobanks. Social science & medicine.
Aug.2011 73:367–74. 1982. [PubMed: 21726926]
34. Knoppers, BM. Populations and Genetics: Legal and Socio-Ethical Perspectives [Internet].
Martinus Nijhoff Publishers; 2003. cited 2012 Oct 8
35. Brunger, F. Problematizing the Notion of “Community” in Research Ethics [Internet]. In:
Knoppers, BM., editor. Populations and Genetics: legal and Socio-Ethical Perspectives. Martinus
Nijhoff Publishers; Leiden: 2003. p. 245-256.
Haldeman et al. Page 16






















36. Weijer, C. Cambridge Quarterly of Health Care Ethics. 1999. Philosophical and Pragmatic
Challenges; p. 501-513.
37. Gbadegesin S, Wendler D. Protecting communities in health research from exploitation. [Internet].
Bioethics. Sep.2006 20:248–53. [PubMed: 17100008]
38. Lidz CW, Simon LJ, Seligowski AV, Myers S, Gardner W, Candilis PJ, et al. The participation of
community members on medical institutional review boards. Journal of empirical research on
human research ethics : JERHRE. Feb.2012 7:1–6. [PubMed: 22378129]
Haldeman et al. Page 17











































Haldeman et al. Page 18
Table 1
Descriptions of the types of biobanks that participated in this study
De-novo Biobanks Re-purposed Biobanks Networked Biobanks
Community Biobank exists as part of a
university but operates over one hundred
miles from campus in a small town setting.
It originated by way of a very large
philanthropic donation from one
individual and its aim is to collect
specimens from all residents of a
particular geographic area. Healthy
individuals are recruited at a variety of
community-based events and doctor’s
visits.
National Biobank is funded by a national
governing body and recruits healthy
participants within one state’s geographic
limits. National Biobank collaborates with
a local university in its sample collection.
Participants were initially recruited in
family practice settings using leftover
specimens, but in 2006, recruitment
shifted to actively requesting samples
from healthy participants.
Hospital Biobank is housed within a
large university and acquires both
healthy and non-healthy volunteers from
opportunistic hospital and university
employee populations and maintains an
opt-out format for consent. Specimens
collected for other clinical reasons are
re-purposed for use in this biobank.
State Biobank is a state-run biobank
that, through an opt-in consent process,
collects leftover dried bloodspots
originally collected for newborn
screening. This large biobank aims to
make use of these specimens for a wide
variety of medical and public health
research efforts.
Advocacy Biobank is a consortium
of advocacy based, disease-
focused organizations that stores
samples in one repository for use
by researchers worldwide.
Disease-Focused Biobank is part
of a research network of academic
institutions that specifically collect
specimens from hospital
populations of patients with HIV/
AIDS. We interviewed biobank
employees from each of two
universities in the network.
Disease-Focused Biobank
specimens are shared with the
larger network to advance HIV
research.
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Table 2
Interview Topics and Sample Questions
Interview Topic Sample Questions
Mission • What is the mission of the bank?
• What are the bank’s current short-term goals?
• What are the bank’s current long-term goals?
Structure • Are there any internal conflicts/tensions within the bank’s structure?
• What do you think are some of the risks of running the biobank?
• Thinking about the various divisions or branches [of the bank] how do you think the mission of [the bank] has
influenced the way that it is structured?
Work/Technology • Are there particular ethical considerations that arise in collecting and storing these types of specimens?
• Thinking about the information [the bank] collects from people who contribute specimens, what do you see as
the benefits and risks of collecting, storing, and updating this information?
• Are the specimens and data linked to the people who donate specimens? How? What do you call the people
who contribute specimens?
Members • I understand there are (# ) branches in [the bank]. What are the responsibilities of the different branches?
• How has [the bank] changed over time in terms of numbers of employees and their roles?
• How much turnover is there with employees? To what do you attribute the turnover?
Environment • How do potential contributors hear about [the bank]?
• Does the bank maintain communication with its [specimen contributors]? How?
• What does the term “community engagement” mean to you?
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